Table 1.
Clinical characteristics of the participants.
| Variable | Survivors (n = 25) | Nonsurvivors (n = 15) | p-value |
|---|---|---|---|
| Age, years | 78 (52–84) | 83 (76–85) | 0.105 |
| Men | 12 (48) | 12 (80) | 0.046∗ |
| BMI (kg/m2) | 25 (20–29) | 22 (19–28) | 0.224 |
| Primary site of infection | |||
| Lung | 20 (80) | 11 (73.3) | 0.922 |
| Other site | 5(20) | 4 (27) | 0.922 |
| Comorbidities | |||
| COPD | 1 (4) | 1 (6.67) | 1.000 |
| DM | 9 (36) | 3 (20) | 0.476 |
| Hypertension | 13 (52) | 10 (66.7) | 0.364 |
| Cerebrovascular disease | 12 (48) | 6 (40) | 0.622 |
| ARDS | 13 (52) | 10 (67) | 0.364 |
| Duration of MV (days) | 6 (2–10) | 7 (2–14) | 0.594 |
| Length of hospital stay (days) | 17 (12–25) | 15 (6–20) | 0.088 |
Values are expressed as n (%) or median (25%–75%) unless otherwise stated. BMI, body mass index; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; ARDS, acute respiratory distress syndrome; MV, mechanical ventilation.